These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 18471541
1. GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation. Martini F, Sacchi A, Lalle E, Castilletti C, D'Offizi G, Abbate I, Capobianchi MR. Gastroenterology; 2008 May; 134(5):1631-3; author reply 1633. PubMed ID: 18471541 [No Abstract] [Full Text] [Related]
4. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection. Fan Z, Huang XL, Kalinski P, Young S, Rinaldo CR. Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507 [Abstract] [Full Text] [Related]
5. [The role of dendritic cells in the infection by HIV and HCV]. Belmonte L, Parodi C, Bare P, Baston M, Bracco MM, Ruibal-Ares B. Medicina (B Aires); 2007 Sep; 67(1):63-70. PubMed ID: 17408026 [Abstract] [Full Text] [Related]
6. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Ciuffreda D, Comte D, Cavassini M, Giostra E, Bühler L, Perruchoud M, Heim MH, Battegay M, Genné D, Mulhaupt B, Malinverni R, Oneta C, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers JJ, Pantaleo G, Dutoit V. Eur J Immunol; 2008 Oct; 38(10):2665-77. PubMed ID: 18958874 [Abstract] [Full Text] [Related]
7. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence. Hiroishi K, Ito T, Imawari M. J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560 [Abstract] [Full Text] [Related]
8. HIV and hepatitis C coinfection. Matthews GV, Dore GJ. J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597 [Abstract] [Full Text] [Related]
10. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus. Roe B, Hall WW. Expert Rev Mol Med; 2008 Oct 20; 10():e30. PubMed ID: 18928579 [Abstract] [Full Text] [Related]
11. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response. Bode JG, Brenndörfer ED, Häussinger D. Biol Chem; 2008 Oct 20; 389(10):1283-98. PubMed ID: 18713016 [Abstract] [Full Text] [Related]
15. [Anti-virus response and interferon, cytokine systems in patients with chronic hepatitis C]. Makashova VV, Florianu AI. Ter Arkh; 2008 Oct 20; 80(11):7-10. PubMed ID: 19143182 [Abstract] [Full Text] [Related]
18. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection. Hofmann WP, Soriano V, Zeuzem S. Handb Exp Pharmacol; 2009 Oct 20; (189):321-46. PubMed ID: 19048206 [Abstract] [Full Text] [Related]
19. Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: a longitudinal evaluation. Antonucci G, Vairo F, Iacomi F, Comandini UV, Solmone M, Piselli P, Boumis E, Lauria FN, Capobianchi MR, Ippolito G, Puro V. Scand J Infect Dis; 2008 Oct 20; 40(11-12):928-34. PubMed ID: 18651264 [Abstract] [Full Text] [Related]
20. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus. Endo T, Fujimoto K, Nishio M, Yamamoto S, Obara M, Sato N, Koike T. J Med Virol; 2009 Jun 20; 81(6):979-82. PubMed ID: 19382259 [Abstract] [Full Text] [Related] Page: [Next] [New Search]